MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/07853890.2025.2612393

Медицинская библиотека · Annals of medicine · 2026

Management of potentially curable colorectal lung metastases with synchronous systemic therapy and percutaneous image-guided thermal ablation.

Fan Hongjie, Tang Bufu, Dong Xiangjun, Zeng Yulan, Gu Xinyue, Xia Xiangwen, Hu Jihong, Wan Cheng, Ding Rong, Li Xinghai, Zhao Fenhua, Fu Chunlong, Cun Jiangping, Li An, Xie Xuancheng, Xu Shufeng, Qian Kun, Kan Xuefeng, Zheng Chuansheng

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

To assess the survival benefit of synchronous systemic therapy plus thermal ablation (TA) in oligometastatic colorectal lung metastases (CRLM) and identify independent prognostic factors.

BACKGROUND

Optimizing the integration of systemic therapy and TA for potentially curable CRLM remains a significant clinical challenge.

METHODS

This study employed a retrospective cohort design, including 326 patients who underwent TA treatment at six tertiary medical centers from March 2014 to October 2022. Patients were categorized into synchronous therapy, upfront ablation, delayed ablation, and no systemic therapy groups based on the timing of systemic therapy relative to TA. Kaplan-Meier analysis and log-rank tests were used to assess survival outcomes.

RESULTS

Synchronous systemic therapy yielded the longest median progression-free survival (PFS) (22.0 months) and overall survival (OS) (61.3 months) compared to delayed ablation (13.0 and 49.2 months, respectively) and no systemic therapy (11.9 and 29.3 months, respectively) (all p < 0.05). Synchronous systemic therapy was an independent protective factor for PFS [hazard ratio (HR) = 0.493] and OS (HR = 0.211). Independent risk factors for local tumor progression included tumor size ≥3 cm (HR = 1.75) and peridiaphragmatic location (HR = 1.48). For PFS, independent predictors included tumor numbers (p < 0.001), synchronous metastases (HR = 1.431), and extrapulmonary metastases (p = 0.001). OS was adversely influenced by tumor burden (p < 0.05), extrapulmonary metastases (p < 0.001), and mediastinal lymph node involvement (HR = 1.518).

CONCLUSIONS

Synchronous systemic therapy combined with TA significantly enhances PFS and OS in potentially curable oligometastatic CRLM patients.

Для цитирования: Fan Hongjie, Tang Bufu, Dong Xiangjun, Zeng Yulan, Gu Xinyue, Xia Xiangwen, Hu Jihong, Wan Cheng, Ding Rong, Li Xinghai, Zhao Fenhua, Fu Chunlong, Cun Jiangping, Li An, Xie Xuancheng, Xu Shufeng, Qian Kun, Kan Xuefeng, Zheng Chuansheng. Management of potentially curable colorectal lung metastases with synchronous systemic therapy and percutaneous image-guided thermal ablation.. Annals of medicine. 2026. DOI: 10.1080/07853890.2025.2612393.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.